Related Experiment Videos
Cell surface markers and cellular immune response associated with rheumatic heart disease: complex segregation
1Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis.
Genetic Epidemiology
|January 1, 1988
Summary
Genetic factors influence rheumatic heart disease risk markers. Major genes control cell surface glycoproteins and streptococcal responses, with some polygenic influence, indicating complex genetic control.
Area of Science:
- Immunogenetics
- Rheumatic Heart Disease Pathogenesis
- Population Genetics
Background:
- Rheumatic heart disease (RHD) poses a significant health burden, particularly in certain populations.
- Understanding the genetic underpinnings of RHD risk factors is crucial for developing targeted prevention strategies.
- Previous studies suggest a link between specific immune markers and RHD susceptibility.
Purpose of the Study:
- To investigate the genetic contribution to cell surface markers and immune responses associated with increased RHD risk.
- To analyze the segregation of these markers and responses within large kindreds across different ethnic groups.
- To elucidate the role of major genes versus polygenes in immune system variations linked to RHD.
Main Methods:
- Analysis of peripheral blood lymphocytes from nine large kindreds (Maori, Polynesian, Caucasian).
- Evaluation of specific lymphocyte surface markers (monoclonals 83S.19.23 and D8103).
- Assessment of blastogenic response to purified Group A streptococcal extracellular product (Blastogen A).
Main Results:
- Segregation analysis indicated genetic control by single major genes for blastogenic response and cell surface marker expression.
- The influence of polygenes varied across different markers, suggesting heterogeneity.
- This points to complex genetic regulation in immune responses relevant to RHD.
Conclusions:
- Genetic factors, primarily major genes, play a significant role in determining the expression of cell surface markers and blastogenic responses to streptococcal products.
- The observed heterogeneity in polygenic contribution highlights the complexity of immune system genetics in RHD.
- Further research into these genetic factors could inform strategies for RHD prevention and management.